{"id":1631,"date":"2021-07-10T13:37:29","date_gmt":"2021-07-10T06:37:29","guid":{"rendered":"https:\/\/nucleusfarma.com\/en\/?p=1631"},"modified":"2021-07-28T17:27:26","modified_gmt":"2021-07-28T10:27:26","slug":"lolos-uji-kelayakan-jurnal-kedokteran-internasional-nucleus-farma-ciptakan-obat-terapi-untuk-penderita-covid","status":"publish","type":"post","link":"https:\/\/nucleusfarma.com\/en\/lolos-uji-kelayakan-jurnal-kedokteran-internasional-nucleus-farma-ciptakan-obat-terapi-untuk-penderita-covid\/","title":{"rendered":"Lolos Uji Kelayakan Jurnal Kedokteran Internasional, Nucleus Farma Ciptakan Obat Terapi untuk Penderita Covid"},"content":{"rendered":"<p><img loading=\"lazy\" class=\"size-medium wp-image-1275 alignleft\" src=\"https:\/\/nucleusfarma.com\/en\/wp-content\/uploads\/2021\/07\/nucleus-jurnal1-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/nucleusfarma.com\/en\/wp-content\/uploads\/2021\/07\/nucleus-jurnal1-300x200.jpg 300w, https:\/\/nucleusfarma.com\/en\/wp-content\/uploads\/2021\/07\/nucleus-jurnal1-16x12.jpg 16w, https:\/\/nucleusfarma.com\/en\/wp-content\/uploads\/2021\/07\/nucleus-jurnal1.jpg 600w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>Penelitian yang digawangi oleh Prof. Dr. apt. Syamsudin, M.Biomed merupakan Guru Besar bidang Farmakologi Bahan Alam dari Fakultas Farmasi Universitas Pancasila, dr. Lusi Nursilawati Syamsi, Sp.P merupakan praktisi dokter spesialis paru yang menangani Covid-19, Dr.rer.nat. Chaidir Amin dari BPPT dan Dr. Nurita Andayani merupakan ahli statistika.<\/p>\n<p>Sumber :\u00a0<a href=\"https:\/\/www.neraca.co.id\/article\/148913\/lolos-uji-kelayakan-jurnal-kedokteran-internasional-nucleus-farma-ciptakan-obat-terapi-untuk-penderita-covid\">https:\/\/www.neraca.co.id\/article\/148913\/lolos-uji-kelayakan-jurnal-kedokteran-internasional-nucleus-farma-ciptakan-obat-terapi-untuk-penderita-covid<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Penelitian yang digawangi oleh Prof. Dr. apt. Syamsudin, M.Biomed merupakan Guru Besar bidang Farmakologi Bahan Alam dari Fakultas Farmasi Universitas Pancasila, dr. Lusi Nursilawati Syamsi, Sp.P merupakan praktisi dokter spesialis paru yang menangani Covid-19, Dr.rer.nat. Chaidir Amin dari BPPT dan Dr. Nurita Andayani merupakan ahli statistika. Sumber :\u00a0https:\/\/www.neraca.co.id\/article\/148913\/lolos-uji-kelayakan-jurnal-kedokteran-internasional-nucleus-farma-ciptakan-obat-terapi-untuk-penderita-covid<\/p>\n","protected":false},"author":9,"featured_media":1275,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[],"_links":{"self":[{"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/posts\/1631"}],"collection":[{"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/comments?post=1631"}],"version-history":[{"count":3,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/posts\/1631\/revisions"}],"predecessor-version":[{"id":1683,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/posts\/1631\/revisions\/1683"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/media\/1275"}],"wp:attachment":[{"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/media?parent=1631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/categories?post=1631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nucleusfarma.com\/en\/wp-json\/wp\/v2\/tags?post=1631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}